Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bisacodyl and Simeticone for Constipation and Bloatedness
NCT02211976Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Oct 2003
- Primary completion
- Nov 2003
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial in constipation and abdominal bloating comparing Bisacodyl, Simeticone and Bisacodyl + Simeticone (3 arms). Primary endpoint: Change in bloatedness score at 1 hour. Started Oct 2003; status: completed.
02
Drugs
bisacodylsimethicone
03
Conditions
constipationabdominal bloating
Beyond the preview
Go deeper on NCT02211976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02211976.